MEASUREMENT OF ANTITHROMBIN III
HYPHEN BioMed proposes a dedicated and specialized range of reagents for testing plasma anti-thrombotic proteins and cofactors involved in congenital or acquired thrombophilia.
Antithrombin (AT) or Heparin Cofactor I is the major inhibitor of blood coagulation and is essential for effective heparin therapy. By inhibiting the coagulation proteases, especially thrombin, FXa and FIXa, AT prevents uncontrolled coagulation and thrombosis.
Antithrombin deficiency is associated with a high risk of thromboembolic disorders.
MEASUREMENT OF ANTITHROMBIN III
